Cardiac Complications in End-stage Renal Disease: a Shared Care Challenge

Overview

Journal Br J Cardiol

Specialty Cardiology & Vascular Diseases

Date 2022 Jun 24

PMID 35747081

Authors

Xenophon Kassianides

Adil Hazara

Sunil Bhandari

Affiliations

Soon will be listed here.

Citing Articles

Patient reported outcome measures and cardiovascular outcomes following high dose modern intravenous iron in non-dialysis dependent chronic kidney disease: secondary analysis of ExplorIRON-CKD.

Kassianides X, Bhandari S Sci Rep. 2023; 13(1):18401.

PMID: 37884522 PMC: 10603042. DOI: 10.1038/s41598-023-44578-6.

References

Okonko D, Grzeslo A, Witkowski T, Mandal A, Slater R, Roughton M . Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol. 2008; 51(2):103-12. DOI: 10.1016/j.jacc.2007.09.036. View

Wallentin L, Becker R, Budaj A, Cannon C, Emanuelsson H, Held C . Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009; 361(11):1045-57. DOI: 10.1056/NEJMoa0904327. View

Hammer F, Malzahn U, Donhauser J, Betz C, Schneider M, Grupp C . A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients. Kidney Int. 2019; 95(4):983-991. DOI: 10.1016/j.kint.2018.11.025. View

Sacher F, Jesel L, Borni-Duval C, de Precigout V, Lavainne F, Bourdenx J . Cardiac Rhythm Disturbances in Hemodialysis Patients: Early Detection Using an Implantable Loop Recorder and Correlation With Biological and Dialysis Parameters. JACC Clin Electrophysiol. 2018; 4(3):397-408. DOI: 10.1016/j.jacep.2017.08.002. View

Goodman W, Goldin J, Kuizon B, Yoon C, Gales B, Sider D . Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000; 342(20):1478-83. DOI: 10.1056/NEJM200005183422003. View

Ronco C, Bellasi A, Di Lullo L . Cardiorenal Syndrome: An Overview. Adv Chronic Kidney Dis. 2018; 25(5):382-390. DOI: 10.1053/j.ackd.2018.08.004. View

Wiviott S, Braunwald E, McCabe C, Montalescot G, Ruzyllo W, Gottlieb S . Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007; 357(20):2001-15. DOI: 10.1056/NEJMoa0706482. View

Macdougall I, White C, Anker S, Bhandari S, Farrington K, Kalra P . Intravenous Iron in Patients Undergoing Maintenance Hemodialysis. N Engl J Med. 2018; 380(5):447-458. DOI: 10.1056/NEJMoa1810742. View

Roberts P, Zachariah D, Morgan J, Yue A, Greenwood E, Phillips P . Monitoring of arrhythmia and sudden death in a hemodialysis population: The CRASH-ILR Study. PLoS One. 2017; 12(12):e0188713. PMC: 5730159. DOI: 10.1371/journal.pone.0188713. View

10.

Charytan D, Himmelfarb J, Ikizler T, Raj D, Hsu J, Landis J . Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial. Kidney Int. 2018; 95(4):973-982. PMC: 6431563. DOI: 10.1016/j.kint.2018.08.034. View

11.

Jukema J, Timal R, Rotmans J, Hensen L, Buiten M, de Bie M . Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients. Circulation. 2019; 139(23):2628-2638. DOI: 10.1161/CIRCULATIONAHA.119.039818. View

12.

McIntyre C, Burton J, Selby N, Leccisotti L, Korsheed S, Baker C . Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol. 2007; 3(1):19-26. PMC: 2390980. DOI: 10.2215/CJN.03170707. View

13.

Szummer K, Lindhagen L, Evans M, Spaak J, Koul S, Akerblom A . Treatments and Mortality Trends in Cases With and Without Dialysis Who Have an Acute Myocardial Infarction: An 18-Year Nationwide Experience. Circ Cardiovasc Qual Outcomes. 2019; 12(9):e005879. DOI: 10.1161/CIRCOUTCOMES.119.005879. View

14.

Chertow G, Block G, Correa-Rotter R, Drueke T, Floege J, Goodman W . Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med. 2012; 367(26):2482-94. DOI: 10.1056/NEJMoa1205624. View

15.

Poulikakos D, Hnatkova K, Skampardoni S, Green D, Kalra P, Malik M . Sudden Cardiac Death in Dialysis: Arrhythmic Mechanisms and the Value of Non-invasive Electrophysiology. Front Physiol. 2019; 10:144. PMC: 6401645. DOI: 10.3389/fphys.2019.00144. View

16.

Swedberg K, Komajda M, Bohm M, Borer J, Ford I, Dubost-Brama A . Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010; 376(9744):875-85. DOI: 10.1016/S0140-6736(10)61198-1. View

17.

Perkovic V, Jardine M, Neal B, Bompoint S, Heerspink H, Charytan D . Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. N Engl J Med. 2019; 380(24):2295-2306. DOI: 10.1056/NEJMoa1811744. View

18.

Washam J, Holmes D, Thomas L, Pokorney S, Hylek E, Fonarow G . Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF. J Am Heart Assoc. 2018; 7(18):e008928. PMC: 6222961. DOI: 10.1161/JAHA.118.008928. View

19.

Bhandari S, Ives N, Brettell E, Valente M, Cockwell P, Topham P . Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial. Nephrol Dial Transplant. 2015; 31(2):255-61. PMC: 4725389. DOI: 10.1093/ndt/gfv346. View

20.

Pun P, Hellkamp A, Sanders G, Middleton J, Hammill S, Al-Khalidi H . Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study. Nephrol Dial Transplant. 2014; 30(5):829-35. PMC: 4425479. DOI: 10.1093/ndt/gfu274. View